shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8

Ruijun Liu1, Ruili Liu2, Zhiyi Guo1

  • 1Shanghai Lung Tumor Clinical Medicine Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.

Cell Death & Disease
|August 6, 2022
PubMed

Insights

Kinetochore-associated 1 (KNTC1) protein is crucial for cell division and its reduction inhibits non-small-cell lung cancer (NSCLC) progression, proliferation, and migration, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Kinetochore proteins are vital for mitosis and implicated in cancer development.
  • The role of Kinetochore-associated 1 (KNTC1) in non-small-cell lung cancer (NSCLC) is not well understood.
  • Understanding KNTC1's function could reveal new therapeutic strategies for NSCLC.

Purpose of the Study:

  • To investigate the biological significance of KNTC1 in non-small-cell lung cancer (NSCLC).
  • To determine the impact of KNTC1 depletion on NSCLC cell behavior and tumor formation.

Main Methods:

  • Immunohistochemistry was used to assess KNTC1 protein expression in NSCLC tissues.
  • Short hairpin RNA (shRNA) delivered via lentivirus was employed to silence KNTC1 in NSCLC cell lines.
  • Cell viability, proliferation, migration, apoptosis, and in vivo tumor formation were analyzed using various assays (MTT, wound-healing, Transwell, flow cytometry, xenograft models).

Main Results:

  • KNTC1 protein expression was evaluated in NSCLC tissues.
  • Depletion of KNTC1 significantly inhibited NSCLC cell viability, proliferation, migration, and invasion.
  • In vivo studies using a xenograft model confirmed that reduced KNTC1 restrains NSCLC tumorigenesis.
  • Downstream analysis revealed a positive correlation between KNTC1 depletion and PSMB8 expression.

Conclusions:

  • KNTC1 plays a significant role in the progression of non-small-cell lung cancer (NSCLC).
  • KNTC1 acts as a potential therapeutic target for NSCLC treatment.
  • Further research into KNTC1 and its downstream targets like PSMB8 may yield novel therapeutic avenues.

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K